Intercept trial of Obeticholic Acid posted on ClinicalTrials.gov A trial of Intercept's Obeticholic Acid was posted on ClinicalTrials.gov, with a stated main purpose to test the drug' effectiveness when used in patients with moderately severe alcoholic hepatitis. The researchers suspect that individuals with alcoholic hepatitis have certain abnormalities in how their body handles bile acids produced by the liver, the guidance said. Obeticholic acid has "been shown to affect bile acid abnormalities and thus it is possible that obeticholic acid may improve liver condition in individuals with alcoholic hepatitis," the website notes. Shares of Intercept are up 10%, or $27.38, to $305.00 in late morning trading. Reference Link
News For ICPT From The Last 14 Days
Check below for free stories on ICPT the last two weeks.
On The Fly: Analyst Initiation Summary Today's noteworthy initiations include: Ardelyx (ARDX) initiated with a Buy at Citigroup... Century Communities (CCS) initiated with an Overweight at JPMorgan... Charles Schwab (SCHW) initiated with a Buy at Jefferies... Diamondback Energy (FANG) initiated with a Neutral at Sterne Agee... E-Trade (ETFC) initiated with a Hold at Jefferies... Foresight Energy (FELP) initiated with an Overweight at Morgan Stanley... Global Logistics Properties (GBTZF) initiated with an Overweight at Barclays... Intercept (ICPT) initiated with a Buy at Deutsche Bank... Jumei (JMEI) initiated with a Buy at BofA/Merrill... MTS Systems (MTSC) initiated with a Buy at Needham... Markit (MRKT) initiated with an Equal Weight at Morgan Stanley... Opus Bank (OPB) initiated with a Buy at CRT Capital... Parnell (PARN) initiated with an Overweight at Piper Jaffray... TD Ameritrade (AMTD) initiated with a Hold at Jefferies... Teradata (TDC) initiated with a Buy at Standpoint Research... Veritiv (VRTV) initiated with an Overweight at Barclays... Viper Energy (VNOM) initiated with a Market Perform at Raymond James... Yelp (YELP) initiated with an Underweight at Evercore... ZS Pharma (ZSPH) initiated with an Outperform at BMO Capital... Zafgen (ZFGN) initiated with an Outperform at Cowen.